TDM in Special Populations: ICU and Pregnancy | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. TDM in Special Populations: ECMO, CRRT, ARC, and Pregnancy [ Medical Education ](https://mdster.com/blog?category=medical-education) TDM in Special Populations: ECMO, CRRT, ARC, and Pregnancy ============================================================ A practical framework for interpreting drug concentrations when physiology and extracorporeal support disrupt standard pharmacokinetics [ MDster Editorial Team ](https://mdster.com/about) · Sep 01, 2026 · 5 min read · 28 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Critical Care ](https://mdster.com/blog?tag=critical-care) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ Clinical Pharmacology ](https://mdster.com/blog?tag=clinical-pharmacology) [ Therapeutic Drug Monitoring ](https://mdster.com/blog?tag=therapeutic-drug-monitoring) [ Pregnancy Pharmacology ](https://mdster.com/blog?tag=pregnancy-pharmacology) ![TDM in Special Populations: ECMO, CRRT, ARC, and Pregnancy](https://mdster.com/storage/blog/images/tdm-in-special-populations-ecmo-crrt-arc-and-pregnancy.jpg) Share this article Share this post On this page 1. [ Use the Right Mental Model ](#use-the-right-mental-model) 2. [ ECMO and CRRT: Do Not Treat “The Circuit” as One Variable ](#ecmo-and-crrt-do-not-treat-the-circuit-as-one-variable) 3. [ ECMO Primarily Complicates Distribution ](#ecmo-primarily-complicates-distribution) 4. [ CRRT Adds a Dynamic Clearance Pathway ](#crrt-adds-a-dynamic-clearance-pathway) 5. [ ICU Patients and the Augmented Renal Clearance Trap ](#icu-patients-and-the-augmented-renal-clearance-trap) 6. [ Pregnancy: Follow the Patient, Not Just the Reference Range ](#pregnancy-follow-the-patient-not-just-the-reference-range) 7. [ A Practical TDM Workflow ](#a-practical-tdm-workflow) 8. [ Key Takeaways ](#key-takeaways) 9. [ Conclusion ](#conclusion) 10. [ Frequently Asked Questions ](#blog-faqs) 11. [ References ](#references-heading) On this page 1. [ Use the Right Mental Model ](#use-the-right-mental-model) 2. [ ECMO and CRRT: Do Not Treat “The Circuit” as One Variable ](#ecmo-and-crrt-do-not-treat-the-circuit-as-one-variable) 3. [ ECMO Primarily Complicates Distribution ](#ecmo-primarily-complicates-distribution) 4. [ CRRT Adds a Dynamic Clearance Pathway ](#crrt-adds-a-dynamic-clearance-pathway) 5. [ ICU Patients and the Augmented Renal Clearance Trap ](#icu-patients-and-the-augmented-renal-clearance-trap) 6. [ Pregnancy: Follow the Patient, Not Just the Reference Range ](#pregnancy-follow-the-patient-not-just-the-reference-range) 7. [ A Practical TDM Workflow ](#a-practical-tdm-workflow) 8. [ Key Takeaways ](#key-takeaways) 9. [ Conclusion ](#conclusion) 10. [ Frequently Asked Questions ](#blog-faqs) 11. [ References ](#references-heading) A patient on ECMO and CRRT has a low meropenem concentration despite “renal dosing.” Another patient with normal serum creatinine repeatedly misses vancomycin targets. Meanwhile, a pregnant patient develops breakthrough seizures on an unchanged lamotrigine dose. These are not dosing anomalies; they are predictable failures of static pharmacokinetic assumptions. This review reflects evidence available through **September 1, 2026**. In special populations, treat every concentration as one data point within a changing physiological system—not as an isolated laboratory result. Use the Right Mental Model -------------------------- Before adjusting a dose, identify which PK parameter has changed: - An increased **volume of distribution (Vd)** lowers early concentrations and may require an adequate loading dose. - Increased clearance causes underexposure unless the maintenance regimen changes. - Reduced protein binding may lower the total concentration without lowering the pharmacologically active unbound concentration. The board-exam rule remains useful: **loading dose follows Vd; maintenance dose follows clearance**. ECMO and CRRT: Do Not Treat “The Circuit” as One Variable --------------------------------------------------------- ### ECMO Primarily Complicates Distribution ECMO may increase apparent Vd through hemodilution and circuit priming. Circuit components can also sequester drugs, particularly agents that are lipophilic or highly protein bound. However, contemporary adult antibacterial data suggest that renal function, critical illness, and concurrent RRT often explain more PK variability than ECMO settings alone. [\[1\]](#cite-1 "Reference [1]") Do not automatically increase every drug dose during ECMO. Instead, prioritize TDM when exposure is difficult to predict or when treatment failure or toxicity would be consequential. ### CRRT Adds a Dynamic Clearance Pathway For CRRT, think in terms of total clearance: **Total clearance = residual patient clearance + nonrenal clearance + CRRT clearance.** Drug removal varies with delivered effluent rate, protein binding, molecular size, filter characteristics, modality, pre- versus post-filter replacement, adsorption, residual urine output, and circuit downtime. Prescribed CRRT intensity is not necessarily the intensity actually delivered. [\[2\]](#cite-2 "Reference [2]") SituationDominant concernTDM responseECMO initiationLarger Vd or sequestrationConfirm early exposure after loadingActive CRRTExtracorporeal drug clearanceTrack delivered therapy and residual renal functionCRRT interruptionSudden clearance reductionReassess accumulation and toxicity risk Do not reflexively reduce the loading dose because the patient has kidney failure or receives CRRT. Critical illness commonly expands Vd, especially for hydrophilic drugs. Adjust maintenance therapy once total clearance is estimated, then verify exposure. > **Clinical Pearl:** In ECMO plus CRRT, never blame “the circuit” for a low concentration until you have checked the loading dose, residual urine output, delivered effluent, downtime, and sample timing. ICU Patients and the Augmented Renal Clearance Trap --------------------------------------------------- Augmented renal clearance (ARC) is commonly defined as measured CrCl above approximately **130 mL/min/1.73 m²**. It often affects younger patients with trauma, sepsis, neurologic injury, or relatively preserved organ function. A normal or low serum creatinine does not exclude ARC because creatinine production and steady-state assumptions may be unreliable in critical illness. [\[3\]](#cite-3 "Reference [3]") Suspect ARC when renally eliminated drugs remain unexpectedly low despite appropriate administration. High-risk agents include beta-lactams, vancomycin, aminoglycosides, and other hydrophilic drugs with substantial renal elimination. Use a timed urinary CrCl when practical rather than relying solely on an estimating equation. For time-dependent beta-lactams, prolonged or continuous infusion may improve target attainment, but it does not eliminate the need for TDM when assays are available. [\[4\]](#cite-4 "Reference [4]") Common exam pitfalls include: - Reducing doses because a patient is “critically ill” despite evidence of ARC. - Using serum creatinine alone to infer renal drug clearance. - Waiting for clinical failure before measuring exposure. Pregnancy: Follow the Patient, Not Just the Reference Range ----------------------------------------------------------- Pregnancy increases plasma volume, total body water, cardiac output, and renal filtration while reducing albumin and altering several metabolic pathways. The direction and magnitude of change depend on the drug and gestational stage; there is no universal “pregnancy adjustment.” [\[5\]](#cite-5 "Reference [5]") Lamotrigine and levetiracetam concentrations commonly decline during pregnancy. For drugs with strong concentration-response relationships, establish a clinically effective preconception baseline when possible, monitor serially, and interpret levels alongside disease control. [\[6\]](#cite-6 "Reference [6]") Reduced albumin creates another trap. Total phenytoin or tacrolimus concentrations may fall while the unbound fraction increases, so escalating the dose merely to normalize a total level can cause toxicity. Measure free concentrations when validated and available, or interpret total concentrations with protein binding and clinical status in mind. [\[7\]](#cite-7 "Reference [7]") Plan postpartum management before delivery. Pregnancy-related clearance can reverse rapidly, converting an appropriate antepartum dose into a toxic postpartum regimen. A Practical TDM Workflow ------------------------ 1. **Verify the sample:** Confirm dose, administration, sampling time, and laboratory matrix. 2. **Define the target:** Use an exposure target linked to efficacy or toxicity, not an arbitrary number. 3. **Map every clearance pathway:** Include residual kidneys, liver, CRRT, ECMO, interactions, and changing physiology. 4. **Adjust intelligently:** Decide whether the problem requires a loading dose, maintenance change, interval change, or infusion strategy. 5. **Repeat after change:** Recheck following dose adjustment, circuit interruption, renal recovery, delivery, or major fluid shifts. Key Takeaways ------------- - Separate changes in Vd, clearance, and protein binding before interpreting a drug concentration. - ECMO may alter distribution, but renal function and RRT often dominate antimicrobial clearance. - Base CRRT decisions on delivered therapy, downtime, and residual kidney function. - Normal serum creatinine does not exclude ARC; measure urinary CrCl when feasible. - During pregnancy, use individualized baselines and beware misleading total concentrations. - Anticipate postpartum toxicity when pregnancy-driven clearance falls. Conclusion ---------- TDM is most valuable when physiology is changing faster than standard dosing guidance can follow. Measure thoughtfully, interpret mechanistically, and repeat whenever the patient—or the circuit—changes. Frequently Asked Questions ---------------------------- ### When should drug concentrations be repeated during CRRT? Repeat after dose changes, major effluent-rate changes, prolonged circuit downtime, renal recovery, unexpected toxicity, or failure to achieve the clinical response. ### Does ECMO always require higher antimicrobial doses? No. ECMO effects are drug-specific, and adult data suggest renal function, critical illness, and concurrent RRT often have greater influence than ECMO itself. ### How should augmented renal clearance be confirmed? Use a timed urinary creatinine clearance when feasible. Serum creatinine and estimating equations may fail to identify enhanced renal drug elimination in ICU patients. ### Why can total drug levels be misleading during pregnancy? Reduced albumin and altered blood composition can lower total concentrations without proportionally lowering active unbound drug, particularly for highly protein-bound medications. References (9) ------------------ 1. 1. [ Antibacterial Pharmacokinetics in Critically Ill Patients Receiving ECMO: A Systematic Review, 2025 ](https://pubmed.ncbi.nlm.nih.gov/41385144/) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ Therapeutic Drug Monitoring of Antibiotics in Patients Receiving Renal Replacement Therapy ](https://pubmed.ncbi.nlm.nih.gov/34772891/) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ pubmed.ncbi.nlm.nih.gov/29441476 ](https://pubmed.ncbi.nlm.nih.gov/29441476/) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ pubmed.ncbi.nlm.nih.gov/37237773 ](https://pubmed.ncbi.nlm.nih.gov/37237773/) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ pubmed.ncbi.nlm.nih.gov/36822695 ](https://pubmed.ncbi.nlm.nih.gov/36822695/) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ Impact of Pregnancy on the Pharmacokinetics of Antiseizure Medications, 2024 ](https://pubmed.ncbi.nlm.nih.gov/38762161/) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ pubmed.ncbi.nlm.nih.gov/37896215 ](https://pubmed.ncbi.nlm.nih.gov/37896215/) [↩](#cite-ref-7-1 "Back to text") 8. 8. [ Antimicrobial Therapeutic Drug Monitoring in Critically Ill Adult Patients: A Position Paper ](https://pubmed.ncbi.nlm.nih.gov/32383061/) 9. 9. [ Physiologic Changes During Pregnancy and Impact on Drug Disposition ](https://pubmed.ncbi.nlm.nih.gov/37317492/) Next step Turn reading into Internal Medicine performance ------------------------------------------------- - System‑based, exam‑style questions + explanations - Smarter review to reinforce weak topics - Build confidence with measurable progress [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Critical Care ](https://mdster.com/blog?tag=critical-care) [ # Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ # Clinical Pharmacology ](https://mdster.com/blog?tag=clinical-pharmacology) [ # Therapeutic Drug Monitoring ](https://mdster.com/blog?tag=therapeutic-drug-monitoring) [ # Pregnancy Pharmacology ](https://mdster.com/blog?tag=pregnancy-pharmacology) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Pediatric Liver Synthetic Dysfunction: INR and Vitamin K Trial 6 min read Aug 31, 2026 ](https://mdster.com/blog/pediatric-liver-synthetic-dysfunction-inr-and-vitamin-k-trial) [### QI Methods and Measurement in Anesthesiology: PDSA and Charts 5 min read Aug 30, 2026 ](https://mdster.com/blog/qi-methods-and-measurement-in-anesthesiology-pdsa-and-charts) [### CPD and Lifelong Learning in Emergency Medicine: Stay Competent 4 min read Aug 29, 2026 ](https://mdster.com/blog/cpd-and-lifelong-learning-in-emergency-medicine-stay-competent) Related Posts ------------- [ ![Pediatric Liver Synthetic Dysfunction: INR and Vitamin K Trial](https://mdster.com/storage/blog/images/pediatric-liver-synthetic-dysfunction-inr-and-vitamin-k-trial.jpg) Medical Education ### Pediatric Liver Synthetic Dysfunction: INR and Vitamin K Trial Learn how INR reveals pediatric liver synthetic failure, when coagulopathy signals an emergency, and how the vitamin K trial separates deficiency from hepatocyte failure. 6 min read 0 comments ](https://mdster.com/blog/pediatric-liver-synthetic-dysfunction-inr-and-vitamin-k-trial) [ ![QI Methods and Measurement in Anesthesiology: PDSA and Charts](https://mdster.com/storage/blog/images/qi-methods-and-measurement-in-anesthesiology-pdsa-and-charts.jpg) Medical Education ### QI Methods and Measurement in Anesthesiology: PDSA and Charts Learn how anesthesiology teams use PDSA cycles, time-series charts, and the Donabedian framework to measure change and improve perioperative safety. 5 min read 0 comments ](https://mdster.com/blog/qi-methods-and-measurement-in-anesthesiology-pdsa-and-charts) [ ![CPD and Lifelong Learning in Emergency Medicine: Stay Competent](https://mdster.com/storage/blog/images/cpd-and-lifelong-learning-in-emergency-medicine-stay-competent.jpg) Medical Education ### CPD and Lifelong Learning in Emergency Medicine: Stay Competent A practical August 2026 review of CPD, competence maintenance, professional portfolios, and reflective practice for emergency clinicians and board candidates. 4 min read 0 comments ](https://mdster.com/blog/cpd-and-lifelong-learning-in-emergency-medicine-stay-competent) [ ![American Osteopathic Board of Internal Medicine (Internal Medicine Written Exam): Study Tips That Work](https://mdster.com/storage/blog/images/american-osteopathic-board-of-internal-medicine-internal-medicine-written-exam-study-tips.jpg) Study Tips ### American Osteopathic Board of Internal Medicine (Internal Medicine Written Exam): Study Tips That Work Prepare for the AOBIM Internal Medicine Written Exam with a focused eight-week schedule, blueprint-based priorities, timed question practice, and exam-day tactics. 5 min read 0 comments ](https://mdster.com/blog/american-osteopathic-board-of-internal-medicine-internal-medicine-written-exam-study-tips) [ ![Mood, Affect, and Emotional Reactivity: A High-Yield MSE Guide](https://mdster.com/storage/blog/images/mood-affect-and-emotional-reactivity-a-high-yield-mse-guide.jpg) Medical Education ### Mood, Affect, and Emotional Reactivity: A High-Yield MSE Guide Learn to distinguish mood from affect and assess range, congruence, lability, anhedonia, alexithymia, and emotional reactivity during the psychiatric MSE. 5 min read 0 comments ](https://mdster.com/blog/mood-affect-and-emotional-reactivity-a-high-yield-mse-guide) [ ![Confidentiality in Sexual and Reproductive Care: Clinical Rules](https://mdster.com/storage/blog/images/confidentiality-in-sexual-and-reproductive-care-clinical-rules.jpg) Medical Education ### Confidentiality in Sexual and Reproductive Care: Clinical Rules Protect reproductive health information without delaying care. Learn safer messaging, private results workflows, and minimum necessary disclosure principles. 5 min read 0 comments ](https://mdster.com/blog/confidentiality-in-sexual-and-reproductive-care-clinical-rules) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ Download on the App Store ](https://apps.apple.com/app/id6759168258) [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Curriculum](https://mdster.com/curriculum) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://apps.apple.com/app/id6759168258) [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept